在体外敏感性和协同作用比斯木对杆菌的作用
Jieun Woo1, Chang Seok Bang1,2, Jae Jun Lee1,3
1Institute of New Frontier Research, Hallym University College of Medicine, Chuncheon 24252, Gangwon-do, Republic of Korea.
Antibiotics (Basel, Switzerland)
|November 27, 2024
概括
毕斯穆特在体外有效抑制了Helicobacter pylori (H. pylori) 的作用. 研究发现,珠和常见抗生素之间没有协同作用,这表明其他机制可以增强H. pylori根除疗法.
科学领域:
- 微生物学 微生物学
- 药理学 药理学是指药理学的学科.
- 传染性疾病 传染性疾病
背景情况:
- 石是Helicobacter pylori (H. pylori) 根除治疗中的一个关键成分.
- 有限的研究存在于H. pylori在体外对斯木的敏感性.
- 对H. pylori斯木的确切作用机制尚未完全理解.
研究的目的:
- 为了确定对H.pylori菌株的比斯木的抗菌作用.
- 为了评估和常见抗生素之间的潜在协同作用.
- 为了研究pH值对比斯木的抗菌活性的影响.
主要方法:
- 确定了三种对H.pylori的双制剂的最低抑制度 (MIC),使用甲稀释.
- 评估pH值 (5.0-8.0) 对斯木的疗效的影响.
- 使用的棋盘试验检查了合物石亚酸盐 (CBS) 和阿莫西西林,克拉里素或美特罗尼达之间的协同作用.
主要成果:
- 石制剂呈现出不同的MIC:石亚酸盐 (4-32μg/mL),石酸盐 (2-16μg/mL) 和CBS (1-8μg/mL).
- 石的MIC在pH值范围5.0至8.0之间保持一致.
- 在CBS和针对参考H. pylori菌株测试的抗生素之间没有观察到协同效应.
结论:
- 在实验室中,比斯穆特表现出对H.pylori的敏感性.
- 在H. pylori根除中,斯木的增强疗效很可能源于独立于直接抗生素协同作用的机制.
相关概念视频
01:16Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
328
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
328
01:27Combined Effects of Drugs: Synergism
3.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.7K
01:26Peptic Ulcer Disease IV: Management
74
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
74
01:28Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
89
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
89
01:24Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
356
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI) tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
356
01:13Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
358
Peptic ulcers, often induced by H. pylori infections or NSAID usage, arise from disruptions in the delicate balance of gastric acid production. Peptic ulcers stem from heightened gastric acid levels due to H. pylori infections or NSAID use. The protective mucus layer diminishes in the presence of these factors, allowing gastric acid to erode the stomach lining and form ulcers.
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
358